Self medication in migraine and tension-type headache - Evidence-based treatment recommendations of the German Migraine and Headache Society;Selbstmedikation bei migräne und kopfschmerz vom spannungstyp: Evidenzbasierte empfehlungen der Deutschen Migräne- und Kophchmerz-Gesellchaft (DMKG)

Nervenheilkunde

Volumn 23, Issue 7, 2004, Pages 415-430

  Haag, G ^a   Evers, S ^b   May, A ^c   Neu, I S ^d   Vivell, W ^e   Ziegler, A ^f  

^a Michael Balint Klinik   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d Abteilung für Neurologie   (Germany)

^e Jahnapotheke   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Migraine; Self medication; Tension type headache; Treatment recommendations

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ASCORBIC ACID; CAFFEINE; CYCLANDELATE; IBUPROFEN; IBUPROFEN LYSINE; MAGNESIUM; NAPROXEN; PARACETAMOL; PHENAZONE; PROPYPHENAZONE;

DISEASE CLASSIFICATION; DOSE RESPONSE; EVIDENCE BASED MEDICINE; GERMANY; HEADACHE; IDIOPATHIC DISEASE; MEDICAL SOCIETY; MIGRAINE; REVIEW; SELF MEDICATION; TABLET;

EID: 6044273740     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Altman DG. Better reporting of randomized controlled trials: the CONSORT statement. Br Med J 1996; 313: 570-1.
2. Altman DG, Gore SM. Statistics in practice. Articles from The British Medical Journal. London: British Medical Association 1982.
3. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998; 51: 1357-65.
4. Antes G, Bassler D, Galandi D. Systematische Übersichtsarbeiten. Ihre Rolle in einer Evidenz-basierten Gesundheitsversorgung. Dt Ärztebl 1999; 96: A616-22.
5. Bosse K, Kühner A. Behandlung von Kopfschmerzen verschiedenster Genese. Therapiewoche 1988; 38: 3879-84.
6. Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G. Double-blind comparison of an acetaminophen 400 mg - codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia 1994; 14: 156-61.
7. Brandon RA, Eadie MJ, Curran AC, Nolan PC, Presneill JJ, Patterson MC. A new formulation of aspirin: bioavailability and analgesic efficacy in migraine attacks. Cephalalgia 1986; 6: 19-27.
8. Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. Headache 2001; 41: 665-79.
9. Dahlöf CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996; 16: 117-23.
10. Demirkaya S, Dora B, Topcuoglu MK, Ulas UH, Vural A. comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain 2000; 1: 179-86.
11. Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichoralphenazone combination: a double-blind, crossover trial. Headache 1976; 15: 282-7.
12. Diamond S. Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 1983; 23: 206-10.
13. Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000; 68: 312-9.
14. Dickersin K, Scherer R, Lefebvre C. Systematic reviews: identifying relevant studies for systematic reviews. Br Med J 1994; 309: 1286-91.
15. Diener HC, Kaube H, Limmroth V. A practical guide to the management of migraine. Drugs 1998; 56: 811-24.
16. Diener HC, Kaube H, Limmroth V. Antimigraine drugs. J Neurol 1999; 246: 515-9.
17. Diener HC, Krupp P, Schmitt T, Steitz G, Milde K, Freytag S. Cyclandelate in the prophylaxis of migraine - a placebo-controlled study. Cephalalgia 2001; 21: 66-70.
18. Evans M, Pollock A. A score system for evaluating random control clinical trials of prophylaxis of abdominal surgical wound infection. Br J Surg 1985; 72: 256-60.
19. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999; 246: 802-9.
20. Feinstein AR, Heinemann LAJ, Dalessio D, Fox JM, Goldstein J, Haag G, Ladewig D, O'Brien CP. Ad Hoc Review Committee: Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin Parmacol Ther 2000; 68: 457-67.
21. Forth W, Henschler D, Rummel W, Förstermann U, Starke K (Hrsg). Allgemeine und spezielle Pharmakologie und Toxikologie. München: Urban & Fischer 2001.
22. Friedman LM, Furberg CD, DeMets DL, Fundamentals of Clinical Trials. Boston: John Wright PSG Inc 1982.
23. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986; 292: 746-50.
24. Garbe E, Rohmel J, Gundert-Remy U. Clinical and statistical issues in therapeutic equivalence trials. Eur J Clin Pharmacol 1993; 45: 1-7.
25. Gerber WD, Schellenberg R, Thorn M, Bölsche F, Wedekind W, Niederberger U, Soyka D. Cyclandelate versus propranolol in the prophylaxis of migraine - a double-blind placebo-controlled study. Funct Neurol 1995; 10: 27-35.
26. Goadsby PJ. The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci 1999; 26 Suppl 3: S20-S26.
27. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002; 346: 257-68.
28. Göbel H, Soyka D, Ziegler A, Diener HC. Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp. DAZ 1995; 135: 763-78.
29. Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D. Effektivitat von Oleum menthae piperitae und von Paracetamol in der Therapie des Kopfschmerzes vom Spannungstyp. Nervenarzt 1996; 67: 672-81.
30. Goldstein J, Hoffman HD, Armellino JJ, Battikha JP, Hamelsky SW, Couch J, Blumenthal H, Lipton RB. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia 1999; 19: 684-91.
31. Gotzsche PC. Multiple publication of reports of drug trials. Eur J Clin Pharmacol 1989; 36: 429-32.
32. Greenhalgh T. How to read a paper - The basics of evidence based medicine. London: Br Med J Publishing Group 1997.
33. Grimshaw J, Eccles M, Russell I. Developing clinically valid practice guidelines. J Eval Clin Pract 1995; 1: 37-48.
34. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharm Therap 2000; 38: 430-5.
35. Haag G. Kombinationsanalgetika in der Kopfschmerztherapie. DAZ 1998; 138: 229-34.
36. Hakkarainen H, Vapaatalo H, Gothoni G, Parantainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 1979; 2: 326-8.
37. th edition. New York: Graw Hill 1995.
38. Helou A, Lorenz W, Ollenschlager G, Reinauer H, Schwartz FW. Methodische Standards der Entwicklung evidenz-basierter Leitlinien in Deutschland. Konsens zwischen Wissenschaft, Selbstverwaltung und Praxis. Z Aerztl Fortbild Qualitaetssich 2000; 94: 330-9.
39. Helou A, Perleth M, Schwartz FW. Prioritätensetzung bei der Entwicklung medizinischer Leitlinien, Teil 1: Kriterien, Verfahren und Akteure: eine methodische Bestandsaufnahme internationaler Erfahrungen. Z Aerztl Fortbild Qualitaetssich 2000; 94: 53-60.
40. Hilgers RD. Qualitätsbeurteilung von Studien zur klinischen Effektivität. In: Lauterbach KW, Schrappe M (Hrsg). Gesundheitsö konomie, Qualitätsmanagement und Evidence-based Medicine. Stuttgart: Schattauer 2001; 89-95.
41. Hill CL, LaValley MP, Felson DT. Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 2002; 46: 779-84.
42. Hoernecke R, Doenicke A. Behandlung des Migräneanfalls: die Kombination Dihydroergotamintartrat und Paracetamol im Vergleich zu den Einzelsubstanzen und Placebo. Med Klin 1993; 88: 642-8.
43. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Br Med J 1999; 319: 670-4.
44. Hwang IK, Morikawa T. Design issues in noninferiority/equivalence trials. Drug Information J 1999; 33: 1205-18.
45. IHS Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine (first edition). Cephalalgia 1991; 11: 1-12.
46. IHS Committee on Clinical Trials. Guidelines for trials of drug treatments in tension-type headache (first edition). Cephalalgia 1995; 15: 165-79.
47. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
48. Kalso E, Moore RA. Five easy pieces on evidence-based medicine (2). Eur J Pain 2000; 4: 321-4.
49. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, Wilkes K, Furey SA, Subramanian T, Cooper SA. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 2000; 20: 233-43.
50. Kubitzek F, Ziegler G, Gold MS, Liu J-M H, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003; 7: 155-62.
51. Lange R, Lentz R. Comparison of ketoprofen, ibuprofen and naproxen sodium in the treatment of tension-type headache. Drugs Exp Clin Res 1995; 21: 89-96.
52. Lange R, Schwarz JA, Hohn M. Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2000; 20: 663-7.
53. Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache 1987; 27: 90-5.
54. Limmroth V, Katsarava Z, Diener HC. Acetylsalicylic acid in the treatment of headache. Cephalalgia 1999; 19: 545-51.
55. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain. Arch Neurol 1998; 55: 210-7.
56. Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Int Med 2000; 160: 3486-92.
57. Martínez-Martin P, Rafiaelli Jr E, Titus F, Despuig J, Fragoso YD, Díez-Tejedor E, Liano H, Leira R, Cornet ME, van Toor BSJ, Cámara J, Peil H, Vix JM, Ortiz JM and the Cooperative Study Group. Efficacy and safety of metamizol vs. acetylsalicylic in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001; 21: 604-10.
58. Matchar DB, Young WB, Rosenberg JH, Pietrzak MP, Silberstein SD, Lipton RB, Ramadan NM. Evidence-based guidelines for migraine headache in primary care settings: pharmacological management of acute attacks. American Academy of Neurology http://www.aan.com 2000; 1-58.
59. McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford: Oxford University Press 1998.
60. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994; 56: 576-86.
61. Miller DS, Talbot CA, Simpson W, Korey A. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache 1987; 27: 392-6.
62. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-4.
63. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13.
64. Moher D, Schulz KF, Altman DG for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallelgroup randomized trials. Lancet 2001; 357: 1191-4.
65. Moore N, Van Ganse E, Le Parc J-M, Wall R, Schneid H, Farhan M, Verirere F, Pelen F. The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. Clin Drug Invest 1999; 18: 89-98.
66. Murray WJ. Evaluation of aspirin in treatment of headache. Cin Pharmacol Ther 1964; 5: 21-5.
67. Nappi G, Sandrini G, Savoini G, Cavallini A, de Rysky C, Micieli G. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine. Drugs 1987; 33 Suppl: 103-9.
68. Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995; 15: 531-5.
69. Olesen J, Tfelt-Hansen P, Welch KMA (eds). The headaches. New York; Raven Press 1993.
70. Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, Jayawardena S. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000; 40: 561-7.
71. Parfitt K. Analgesics, anti-inflammatory drugs and antipyretics - aspirin. In: Parfitt K (ed). Martindale - The complete drug reference; 32th edition. London: Pharmaceutical Press 1999.
72. Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 1983; 3: 129-34.
73. Peikert A, Wilimzig C, Kühne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16: 257-63.
74. Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 1983; 74: 36-42.
75. Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H. Magnesium in the prophylaxis of migraine - a double-blind, placebo-controlled study. Cephalalgia 1996; 16: 436-40.
76. Pocock SJ. Clinical Trials - A Practical Approach. Chichester: John Wiley & Sons 1983.
77. Pradalier A, Vincent D. Migraine et anti-inflammatoires non-steroidiens. Pathol Biol 1992; 40: 397-405.
78. Prescott LF. Paracetamol (Acetaminophen). A Critical Bibliographic Review. London: Taylor and Francis 1996.
79. Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 2002; 22: 740-8.
80. Rainsford KD (ed). Ibuprofen - A Critical Bibliographic Review. London: Taylor and Francis 1999.
81. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J 1996; 312: 71-2.
82. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine - how to practice and teach EBM. Edinburgh: Churchill Livingstone 2000.
83. Sauerland S, Neugebauer E. Qualität von Meta-Analysen. In: Lauterbach KW, Schrappe M (Hrsg). Gesundheitsökonomie, Qualitä smanagement und Evidence-based Medicine. Stuttgart: Schattauer 2001; 89-95.
84. Sauerland S, Galandi. Cochrane Collaboration und Cochrane Library. In: Lauterbach KW, Schrappe M (Hrsg). Gesundheitsökonomie, Qualitä tsmanagement und Evidence-based Medicine. Stuttgart: Schattauer 2001; 84-8.
85. Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988; 28: 471-4.
86. Schachtel BP, Thoden WR, Konerman JP, Brown A, Chaing DS. Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents. Clin Pharmacol Ther 1991; 50: 322-9.
87. Schachtel BP, Furey SA, Thoden WR. Non-prescription ibuprofen and acetaminophen in the treatment of tension-type headache. J Clin Pharmacol 1996; 36: 1120-5.
88. Schoenen J. Traitements antimigraineux: present et avenir. Rev Med Liege 1999; 54: 79-86.
89. Schoenen J. Traitement des cephalees de tension. Rev Neurol (Paris) 2000; 156 (Suppl 4): 4S87-4S92.
90. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in contolled trials. JAMA 1995; 273: 408-12.
91. Schulz KF. The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines. Ann Neurol 1997; 41: 569-73.
92. Schulz KF, Grimes DA. Blinding in randomized trials: hiding who got what. Lancet 2002; 359: 696-700.
93. Silberstein SD, Armellino JJ, Hofman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Therap 1999; 21: 475-91.
94. Silberstein SD, Rosenberg J. Multispeciality consensus on diagnosis and treatment of headache. Neurology 2000; 54: 1553.
95. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: Isis Medical Media 1998.
96. Spilker B. Guide to clinical studies and developing protocols. New York: Raven Press 1984.
97. Spilker B. Guide to clinical interpretation of data. New York: Raven Press 1986.
98. Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003; 23: 59-66.
99. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 1926-31.
100. Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984; 4: 107-11.
101. van Gerven JM, Schoemaker RC, Jacobs LD, Reints A, Ouwersloot-van der Meij MJ, Hoedemaker HG, Cohen AF. Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996; 42: 475-81.
102. von Graffenried B, Nuesch E. Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol 1980; 10 Suppl: 225S-231S.
103. Walach H, Haeusler W, Lowes T, Mussbach D, Schamell U, Springer W, Stritzl G, Gaus W, Haag G. Classical homeopathic treatment of chronic headaches. Cephalalgia 1997; 17: 119-26.
104. Waldvogel HH. Analgetika Antinozizeptiva Adjuvanzien - Handbuch für die Schmerzpraxis. 2. Auflage. Berlin: Springer 2001.
105. th edition. Edinburgh; Churchill Livingstone 1994.
106. Whitmarsch TE, Coleston-Shields DM, Steiner TH. Double-blind randomised placebo-controlled study of homeopathic prophylaxis of migraine. Cephalalgia 1997; 17: 600-4.
107. Wood AJ, von Graffenried B. Fluproquazone: analgesic activity in outpatients with non-migrainous headache. Arzneim Forsch Drug Res 1981; 31: 914-7.
108. Zenz M, Jurna I. Lehrbuch der Schmerztherapie. 2. Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft 2001.